UAE Approves First Needle-Free Allergy Treatment Spray

Parents racing against time during their child's allergic reaction no longer need to worry about fumbling with needles. The UAE just approved EURneffy, the region's first nasal adrenaline spray that treats severe allergies as easily as using a simple nose spray.

The Emirates Drug Establishment greenlit this game-changing treatment for adults and children as young as four. It delivers the same life-saving epinephrine found in traditional EpiPens, but through a quick spray up the nose instead of a stressful injection.

For anyone who's ever hesitated during an emergency because of needle anxiety, this changes everything. The nasal spray removes that critical barrier when seconds matter most, allowing parents, teachers, or even strangers to help someone in anaphylactic shock without medical training.

Dr. Fatima Al Kaabi, who leads the Emirates Drug Establishment, emphasized how this aligns with the UAE's commitment to bringing innovative treatments to patients faster. The approval came remarkably quickly after officials discovered the product during a recent visit to Denmark and worked directly with manufacturer ALK Abelló to fast-track its availability.

The spray comes in two strengths (1mg and 2mg) with dosing based on body weight. Studies show that delays in administering epinephrine significantly worsen outcomes, so anything that speeds up treatment saves lives.

The Ripple Effect

This approval sends waves beyond the UAE's borders. By becoming the first Middle Eastern country to authorize this treatment, the UAE is paving the way for neighboring nations to follow suit, potentially helping millions across the region who live with severe allergies.

The move also demonstrates how modern regulatory frameworks can balance speed with safety. The Emirates Drug Establishment proved that rigorous approval processes don't have to crawl at a snail's pace when lives hang in the balance.

Ghassan Al Qatib from ALK Abelló noted that making effective, easy-to-use emergency treatments accessible represents a major step forward for patient care. The collaboration between the company and UAE regulators shows what's possible when innovation meets responsive governance.

For families managing severe allergies to foods, insect stings, or medications, this nasal spray offers both practical relief and peace of mind knowing help comes without the added trauma of needles during already terrifying moments.